May 2020

Am I Still At Risk For Cancer From Belviq? Belviq (lorcaserin) is a prescription weight-management drug prescribed to aid in weight loss when taken in combination with a nutrition and physical exercise program. In early 2020, Belviq’s manufacturer withdrew it from the market at the request of the United States Food and Drug Administration (FDA), […]

It was once touted as a new option for those who are obese, overweight, or suffering from weight-related medical conditions. However, many people that were prescribed Belviq or Belviq XR to help them lose weight in a long-term clinical trial reported feeling unwell years into the study. In fact, many users reported that the drug

In February 2020, the manufacturer of the weight-management drug Belviq (lorcaserin) withdrew it from the market at the request of the United States Food and Drug Administration (FDA). This extraordinary step followed the FDA expressing concern that people taking Belviq ran an elevated risk of developing deadly cancers. For answers to specific questions about your

How To Know if Belviq Injured You In February 2020, pharmaceutical manufacturer Eisai, Inc. withdrew its weight-management drug Belviq (generic name lorcaserin) from the U.S. market at the request of the United States Food and Drug Administration (FDA) after a clinical trial identified an increased occurrence of cancer in people who took it. This extraordinary

Many patients took Belviq assuming that it would support their weight loss goals and help them feel more confident in their bodies. Unfortunately, while Belviq might have produced the desired results, it also came with a hefty cost: increased risk of pancreatic, lung, and colorectal cancers. According to a study, 7.7 percent of patients who